Guggenheim initiated coverage of GeneDx (WGS) with a Buy rating and $88 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx Holdings: Positioned for Growth in Whole Genome Sequencing with Strong NICU Market Potential
- GeneDx management to meet with BTIG
- GeneDx Holdings: Strong Buy Rating Backed by Projected Growth and Competitive Edge
- GeneDx upgraded to Buy from Hold at Jefferies
- GeneDx price target lowered to $110 from $135 at TD Cowen
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue